Ma. Mcintosh et al., THE EFFECTS OF OPIOID-PEPTIDES ON CARDIOVASCULAR FUNCTION AND SYMPATHETIC NEUROTRANSMISSION IN RATS, Journal of Pharmacy and Pharmacology, 47(1), 1995, pp. 52-58
The haemodynamic effects of three opioid receptor agonists, with some
preferential activity on delta-, mu- and kappa-receptors were investig
ated in anaesthetized and pithed rats, and effects on sympathetic neur
otransmission were also investigated in pithed rats. In anaesthetized
rats, D-Ala(2)-D-Leu(5)-enkephalin (DADLE) (a predominantly delta-rece
ptor agonist, 10 mu gkg(-1)), glyol (mu, 0.5 mgkg(-1)) and enylacetami
no-2-C3-carboxy-phenylethyl-pyrrolidine (ICI 204448) (kappa, 0.1 mgkg(
-1)) by intravenous administration transiently decreased heart rate fr
om 462 +/- 12 to 432 +/- 14, 460 +/- 12 to 448 +/- 13 and 460 +/- 12 t
o 448 +/- 11 beats min(-1), respectively, and mean arterial blood pres
sure from 142 +/- 6 to 111 +/- 9, 141 +/- 6 to 122 +/- 5 and 148 +/- 7
to 121 +/- 6 mmHg, respectively. The effects of DADLE, but not those
of glyol or ICI 204448, were blocked by M8008, a delta-receptor antago
nist. In pithed rats, none of the opioid agonists had any significant
effects on heart rate or mean arterial blood pressure; however, acetyl
choline significantly reduced both heart rate and mean arterial blood
pressure. All three opioid agonists reduced the positive chronotropic
response to thoracic (C7-T2) spinal cord stimulation in pithed rats, b
y 17 +/- 4, 30 +/- 2 and 20 +/- 10% for DADLE, glyol and ICI 204448, r
espectively. This compared with a 48 +/- 15% reduction with clonidine
(5 mu gkg(-1)). This effect of DADLE was almost abolished by M8008. It
is concluded that the haemodynamic effects of the opioid agonists stu
died are mediated via actions on the central nervous system and that a
decrease in sympathetic neurotransmission may account for, at least i
n part, the bradycardia produced by opioid agonists in intact anaesthe
tized rats. It seems that the sympathetic nervous system is unlikely t
o be involved in the arrhythmogenic effects of opioid peptides.